22 /100
LOW RISK
Score updated May 29, 2026

NMRA — Neumora Therapeutics, Inc. Dilution Risk Tracker

Track NMRA dilution risk with DilutionWatch's stock tracker. DilutionScore™ measures dilution risk across 5 factors — lower scores indicate higher risk of share dilution.

⚠️ Not financial advice. Do your own research before making any investment decisions.

🔔 Track NMRA — Get alerts when the score changes →

📊 Score Breakdown

📋 Offering Ability
20
💰 Cash Runway
25
📊 Float Risk
32
⚠️ Warrant Exposure
15
🔄Convertible Debt

🌦️ Dilution Forecast

☀️
Clear
No significant dilution signals
7%
🔄 Reverse Split 15%
• 52-week low $0.69 has breached $1
🔔 Track NMRA — Get forecast alerts →

💹 Market Data

Market Cap$348.33M
Shares Outstanding185.28M
Float104.83M
Cash$182.53M
Debt$55.01M
Short InterestN/A

🏛 Institutional Holdings

QoQ: ↑ 17.3% shares (2025Q4 vs prior)
100 institutional holders · 63.38M shares
#1 SOFTBANK GROUP CORP. 6.43M shares
#2 Siren, L.L.C. 6.29M shares
#3 VANGUARD GROUP INC 4.54M shares
+ 17 more holders Sign up free to view →

📉 Short Interest

Short Interest4.60M
Days to Cover3.4
% of Float4.4%
FINRA data as of Apr 30, 2026

📁 Recent SEC Activity

xbrl XBRL CONVERTIBLE Dec 31, 2025
xbrl XBRL WARRANT Dec 31, 2022
Full SEC filing analysis available with free account

📰 Recent News

No recent news
Track NMRA Dilution Risk in Real-Time
Get instant alerts when SEC filings impact dilution risk. Free tier available.
Start Tracking NMRA — Free
Real-time SEC alerts DilutionScore™ tracking No credit card required
🔬 More Research for NMRA
📊 NMRA FDA Catalyst Timeline & Biotech Grade — BiotechSigns 📡 NMRA Signal Convergence & Dark Pool Activity — StonkWhisper

Part of the Guerilla Finance research network. Cross-reference multiple data sources for better due diligence.